by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of...
by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) — Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, announced the creation of the company’s scientific advisory...
by GlobeNewsWire | Aug 18, 2016 | Globe Newswire
NOVATO, Calif., Aug. 18, 2016 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Nasdaq:RPTP) announced today that it was named among the top workplaces in the North Bay in the 11th Annual North Bay Business Journal competition. The results of the best places to...
by GlobeNewsWire | Aug 10, 2016 | Globe Newswire
CRANBURY, N.J., Aug. 10, 2016 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of rare and orphan diseases, today announced that data from the pivotal Phase 3 Study 011 (FACETS) evaluating the efficacy and safety of...
by GlobeNewsWire | Aug 10, 2016 | Globe Newswire
CRANBURY, N.J., Aug. 10, 2016 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD), a biotechnology company at the forefront of rare and orphan diseases, today announced that data from the pivotal Phase 3 Study 011 (FACETS) evaluating the efficacy and safety of...